Long-Term Results of Hybrid Left Ventricular Reconstruction in the Treatment of Ischemic Cardiomyopathy

The evidence supporting surgical aneurysmectomy in ischemic heart failure is inconsistent. The aim of the study was to describe long-term effect of minimally invasive hybrid transcatheter and minithoracotomy left ventricular (LV) reconstruction in patients with ischemic cardiomyopathy. Twenty-three...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiovascular translational research Vol. 14; no. 6; pp. 1043 - 1050
Main Authors Naar, Jan, Skalský, Ivo, Krűger, Andreas, Málek, Filip, Van Bladel, Kevin, Annest, Lon S., Moučka, Petr, Mráz, Tomáš, Reddy, Vivek Y., Neužil, Petr
Format Journal Article
LanguageEnglish
Published New York Springer US 01.12.2021
Subjects
Online AccessGet full text
ISSN1937-5387
1937-5395
1937-5395
DOI10.1007/s12265-021-10133-9

Cover

More Information
Summary:The evidence supporting surgical aneurysmectomy in ischemic heart failure is inconsistent. The aim of the study was to describe long-term effect of minimally invasive hybrid transcatheter and minithoracotomy left ventricular (LV) reconstruction in patients with ischemic cardiomyopathy. Twenty-three subjects with transmural anterior wall scarring, LV ejection fraction 15–45%, and New York Heart Association class ≥ II were intervened using Revivent TC anchoring system. LV end-systolic volume index was reduced from 73.2 ± 27 ml at baseline to 51.5 ± 22 ml after 6 months ( p < 0.001), 49.9 ± 20 ml after 2 years ( p < 0.001), and 56.1 ± 16 ml after 5 years ( p = 0.047). NYHA class improved significantly at 5 years compared to baseline. Six-min walk test distance increased at 2 years compared to the 6-month visit. Hybrid LV reconstruction using the anchoring system provides significant and durable LV volume reduction during 5-year follow-up in preselected patients with ischemic heart failure. Graphical abstract Legend : Hybrid left ventricular reconstruction using the anchoring system provides significant and durable LV volume reduction throughout 5-year follow-up in preselected patients with ischemic heart failure.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Associate Editor Marat Fudim oversaw the review of this article
ISSN:1937-5387
1937-5395
1937-5395
DOI:10.1007/s12265-021-10133-9